|
|
Docu-menta >
Buscar por Autor Navarro, S
Mostrando resultados 1 a 12 de 12
| Fecha de publicación | Título | Autor(es) | | ene-2020 | Advances in the gene therapy of monogenic blood cell diseases | Bueren, J; Quintana-Bustamante, O; Almarza, E; Navarro, S; Rio, P; Segovia, JC; Guenechea, G |
| 1-oct-2023 | Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia | Lasaga, M; Rio, P; Vilas-Zornoza, A; Planell, N; Navarro, S; Alignani, D; Fernández-Varas, B; Mouzo, D; Zubicaray, J |
| feb-2014 | Generation of iPSCs from Genetically Corrected Brca2 Hypomorphic Cells: Implications in Cell Reprogramming and Stem Cell Therapy | Navarro, S; Moleiro, V; Molina-Estevez, FJ; Lozano, ML; Chinchon, R; Almarza, E; Quintana-Bustamante, O; Mostoslavsky, G; Maetzig, T; Galla, M; Heinz, N; Schiedlmeier, B; Torres, Y; Modlich, U; Samper, E; Rio, P; Segovia, JC; Raya, A; Güenechea, G; Izpisua-Belmonte, JC; Bueren, JA |
| dic-2024 | Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials. | Rio, P; Zubicaray, J; Navarro, S; Gálvez, E; Sánchez-Domínguez, R; Nicoletti, E; Sebastián, E |
| jul-2006 | Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1 | Navarro, S; Meza, MW; Quintana-Bustamante, O; Casado, JA; Jacome, A; McAllister, K; Puerto, S; Surrallés, J; Segovia, JC; Bueren, JA |
| ago-2021 | Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients | Ramírez, MJ; Trujillo-Quintero, JP; Minguillón, J; Bogliolo, M; Río, P; Navarro, S; Casado, JA; ......, ......; Surrallés, J |
| jul-2021 | Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment | Navarro, S; Quintana-Bustamante, O; Sanchez-Dominguez, R; Lopez-Manzaneda, S; Ojeda-Perez, I; Garcia-Torralba, A; Alberquilla, O; Law, K; Beard, BC; Bastone, A; Rothe, M; Villanueva, M; Ramirez, JC; Fañanas-Baquero, S; Nieto-Romero, V; Gutierrez, S; Nicoletti, E; García-Bravo, M; Bueren, JA; Schwartz, JD; Segovia, JC |
| nov-2024 | Prognostic significance of mutation type and chromosome fragility in Fanconi anemia | Ramírez, MJ; Pujol, R; Minguillón, J; Bogliolo, M; Persico, I; Cavero, D; De La Cal, A; Navarro, S; Casado, JA |
| dic-2009 | Rescue of Pyruvate Kinase Deficiency in Mice by Gene Therapy Using the Human Isoenzyme | Meza, NW; Alonso-Ferrero, ME; Navarro, S; Quintana-Bustamante, O; Valeri, A; Garcia-Gomez, M; Bueren, JA; Bautista, JM; Segovia, JC |
| sep-2019 | Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia | Rio, P; Navarro, S; Wang, W; Sánchez-Domínguez, R; Pujol, RM; Segovia, JC; Bogliolo, M; Merino, E; Wu, N |
| 6-abr-2014 | Targeted gene therapy and cell reprogramming in Fanconi anemia | Rio, P; Baños, R; Lombardo, A; Quintana-Bustamante, O; Alvarez, L; Garate, Z; Genovese, P; Almarza, E; Valeri, A; Díez, B; Navarro, S; Torres, Y; Trujillo, JP; Murillas, R; Segovia, JC; Samper, E; Surralles, J; Gregory, PD; Holmes, MC; Naldini, L; Bueren, JA |
| 2022 | Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia | Casado, JA; Valeri, A; Sanchez-Dominguez, R; Vela, P; Lopez, A; Navarro, S; Alberquilla, O; Hanenberg, H; Pujol, R; Segovia, JC; Minguillón, R; Surrallés, J; Díaz de Heredia, C; Sevilla, J; Rio, P; Bueren, JA |
Mostrando resultados 1 a 12 de 12
|
